Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Oct;34(7):772-9.
doi: 10.1007/s10875-014-0083-7. Epub 2014 Aug 2.

XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP

Affiliations
Review

XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP

Stuart G Tangye. J Clin Immunol. 2014 Oct.

Abstract

X-linked lymphoproliferative disease (XLP) is a rare primary immunodeficiency affecting approximately 1-2 per 1 million males. A key feature of XLP is the exquisite sensitivity of affected individuals to disease induced following EBV infection. However, patients can also develop hypogammaglobulinemia and B-cell lymphoma independently of exposure to EBV. XLP is caused by loss-of function mutations in SH2D1A, which encodes the intracellular adaptor molecule SAP. SAP is predominantly expressed in T cells and NK cells, and functions to regulate signal transduction pathways downstream of the SLAM family of surface receptors to control CD4+ T cell (and by extension B cells), CD8+ T cell and NK cell function, as well as the development of NKT cells. The study of XLP had shed substantial light on the requirements for lymphocyte differentiation and immune regulation, which in turn have the potential to be translated into novel treatments for not only XLP patients but individuals affected by EBV-induced disease, impaired humoral immunity and malignancy.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Nature. 2006 Nov 2;444(7115):110-4 - PubMed
    1. J Clin Invest. 2010 Apr;120(4):939-49 - PubMed
    1. Immunity. 2012 Jun 29;36(6):986-1002 - PubMed
    1. J Immunol. 2010 Jul 1;185(1):190-202 - PubMed
    1. N Engl J Med. 1974 Feb 14;290(7):363-7 - PubMed

MeSH terms

Substances

LinkOut - more resources

-